Androgen receptor signaling in prostate cancer development and progression.
about
Steroid hormone receptors and prostate cancer: role of structural dynamics in therapeutic targetingPersistent androgen receptor addiction in castration-resistant prostate cancerPhenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironmentEstrogen-Related Receptors in Breast Cancer and Prostate CancerWnt/β-catenin signalling in prostate cancerAndrogen signaling promotes translation of TMEFF2 in prostate cancer cells via phosphorylation of the α subunit of the translation initiation factor 2A versatile, bar-coded nuclear marker/reporter for live cell fluorescent and multiplexed high content imagingCotargeting HSP90 and Its Client Proteins for Treatment of Prostate Cancer.Network analysis of ChIP-Seq data reveals key genes in prostate cancer.NRIP/DCAF6 stabilizes the androgen receptor protein by displacing DDB2 from the CUL4A-DDB1 E3 ligase complex in prostate cancer.Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis.ETS-targeted therapy: can it substitute for MEK inhibitors?Modulation of trinucleotide repeat instability by DNA polymerase β polymorphic variant R137Q.Hydrogen sulfide represses androgen receptor transactivation by targeting at the second zinc finger module.A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate.Crystal structure of the mineralocorticoid receptor DNA binding domain in complex with DNA.Polyisoprenylated methylated protein methyl esterase as a putative drug target for androgen-insensitive prostate cancer.Molecular phenotyping of immune cells from young NOD mice reveals abnormal metabolic pathways in the early induction phase of autoimmune diabetesSex hormone-dependent tRNA halves enhance cell proliferation in breast and prostate cancers.MicroRNA-185 and 342 inhibit tumorigenicity and induce apoptosis through blockade of the SREBP metabolic pathway in prostate cancer cellsRegulation and methylation of tumor suppressor miR-124 by androgen receptor in prostate cancer cells.Similarities and Distinctions in Actions of Surface-Directed and Classic Androgen Receptor Antagonists.Splicing Factor Prp8 Interacts With NES(AR) and Regulates Androgen Receptor in Prostate Cancer Cells.Androgen receptor serine 81 phosphorylation mediates chromatin binding and transcriptional activation.Research Resource: Androgen Receptor Activity Is Regulated Through the Mobilization of Cell Surface Receptor Networks.Multiple molecular subtypes of triple-negative breast cancer critically rely on androgen receptor and respond to enzalutamide in vivoA Recurrent Germline Mutation in the 5'UTR of the Androgen Receptor Causes Complete Androgen Insensitivity by Activating Aberrant uORF Translation.ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cellsIdentification of Highly Potent Protein Kinase C-Related Kinase 1 Inhibitors by Virtual Screening, Binding Free Energy Rescoring, and in vitro Testing.MicroRNA and Transcription Factor Gene Regulatory Network Analysis Reveals Key Regulatory Elements Associated with Prostate Cancer Progression.TRPM8 channel as a novel molecular target in androgen-regulated prostate cancer cells.Androgen receptor serine 81 mediates Pin1 interaction and activity.Genomic and epigenomic alterations in prostate cancer.An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells.Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance.Estrogen Exhibits a Biphasic Effect on Prostate Tumor Growth through the Estrogen Receptor β-KLF5 Pathway.Nuclear export signal of androgen receptor (NESAR) regulation of androgen receptor level in human prostate cell lines via ubiquitination and proteasome-dependent degradation.Investigation of Histone Lysine-Specific Demethylase 5D KDM5D) Isoform Expression in Prostate Cancer Cell Lines: a System ApproachTemporal changes in the pathologic assessment of prostate cancer.Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression.
P2860
Q26745907-6B6006C0-4ED7-4CBE-BBB2-CFCAA89B8AAEQ26777163-4167DEF4-3F9F-4BFA-8EA9-9A404BDCB906Q27335274-B191BB45-E5E7-4AC2-A629-25A08ADBD396Q28084030-859D0D40-CA84-489C-91AA-3FA92DC4D901Q28269116-FF9549FB-9CA3-49B1-A676-FAEFEED184CCQ28486024-BBF61277-73C8-4E41-85D6-5BC2142EEB1FQ28488026-529449C1-0BDB-4FD9-AA08-89C6D64FBEB6Q30276399-D00C34C8-BECD-4058-B7F9-1303210FBB4FQ30847259-724B9FA2-1AB2-426C-B958-BE72B3F3AC54Q33591581-E942F092-3BAE-4E7D-A10C-AC838520612AQ33624824-B6B9B02F-5445-44C2-BFEA-40E5201BA44FQ33638827-94E6068B-A1DC-4B07-843F-4F4B396942DEQ33643405-1FBDBD60-9CF3-4DB0-B47E-9A99DC7FE456Q33947136-83657EF9-81BA-4FF9-847D-D3C464EF96B8Q34049857-65366217-0024-4776-B894-8B86DAA311F7Q34134160-2BBF4AFD-D461-4856-BED7-2F4F1B934849Q34135178-BA1260F8-7080-4541-B501-3C1DA86CAD99Q34447630-2FDDE7AF-B248-456A-8696-0413BDD8C74DQ34482912-017ED2CD-AC30-4661-B1AB-1DBD74B39610Q34948292-32578DA3-D566-4B69-BBED-8298462AE483Q35363913-24FEAE94-3F61-48B2-B376-2F3F7BB039D4Q35762232-9BED375B-2907-4946-80E2-1C745EB918DAQ35775678-20DFBEE8-549E-4F15-8EC7-1555A0BAF7C2Q35868187-38B0B634-1C8F-472B-9913-7885D29D4628Q35897569-CF4DC0C0-02C5-46A8-BCFB-72FC6A44AC6EQ35946392-3F625B2E-0002-4504-8743-D90F27D02677Q35998094-FCA0C3DA-FE51-45F2-B52D-C12938E02B7CQ36048017-42D526CD-2089-45E6-B53B-02A1A003656CQ36089876-F539D4C5-6637-4C58-AECF-1248E86AE32EQ36231493-F76857A8-BFD3-40DF-BD2F-EAA24A987E50Q36232009-852E97E1-0D3F-4CAA-A4DE-035509CFDBB2Q36304172-CA66EB94-2696-4928-9E05-026A3D16D12BQ36374578-68E4165F-7D9F-4985-98DC-4EC90FFE4D30Q36389442-9D70CEB2-CFCE-4264-AFE4-2F51C3ACD557Q36398998-16CBE695-24E9-4603-BA38-306B748D1A48Q36434014-9506756C-9469-4588-A140-75E554843DE1Q36439635-7F20A715-7690-4DE4-9928-739175E35176Q36502209-4CFF667A-C947-469F-8FDC-989E7B83972FQ36520474-4FDA0B27-AED1-4C7A-B4F5-0BCC8C0F6646Q36642876-50BB67ED-55EF-4B25-93E7-AD104891DDCA
P2860
Androgen receptor signaling in prostate cancer development and progression.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Androgen receptor signaling in prostate cancer development and progression.
@ast
Androgen receptor signaling in prostate cancer development and progression.
@en
type
label
Androgen receptor signaling in prostate cancer development and progression.
@ast
Androgen receptor signaling in prostate cancer development and progression.
@en
prefLabel
Androgen receptor signaling in prostate cancer development and progression.
@ast
Androgen receptor signaling in prostate cancer development and progression.
@en
P2860
P356
P1476
Androgen receptor signaling in prostate cancer development and progression.
@en
P2093
Donald J Tindall
Peter E Lonergan
P2860
P356
10.4103/1477-3163.83937
P407
P577
2011-08-23T00:00:00Z